Cargando…
Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician
Molecular imaging continues to influence every aspect of cancer care including detection, diagnosis, staging and therapy response assessment. Recent advances in the understanding of cancer biology have prompted the introduction of new targeted therapy approaches. Precision medicine in oncology has l...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541087/ https://www.ncbi.nlm.nih.gov/pubmed/28396911 http://dx.doi.org/10.1007/s00259-017-3695-3 |
_version_ | 1783254747387527168 |
---|---|
author | Lheureux, S. Denoyelle, C. Ohashi, P. S. De Bono, J. S. Mottaghy, F. M. |
author_facet | Lheureux, S. Denoyelle, C. Ohashi, P. S. De Bono, J. S. Mottaghy, F. M. |
author_sort | Lheureux, S. |
collection | PubMed |
description | Molecular imaging continues to influence every aspect of cancer care including detection, diagnosis, staging and therapy response assessment. Recent advances in the understanding of cancer biology have prompted the introduction of new targeted therapy approaches. Precision medicine in oncology has led to rapid advances and novel approaches optimizing the use of imaging modalities in cancer care, research and development. This article focuses on the concept of targeted therapy in cancer and the challenges that exist for molecular imaging in cancer care. |
format | Online Article Text |
id | pubmed-5541087 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-55410872017-08-17 Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician Lheureux, S. Denoyelle, C. Ohashi, P. S. De Bono, J. S. Mottaghy, F. M. Eur J Nucl Med Mol Imaging Review Article Molecular imaging continues to influence every aspect of cancer care including detection, diagnosis, staging and therapy response assessment. Recent advances in the understanding of cancer biology have prompted the introduction of new targeted therapy approaches. Precision medicine in oncology has led to rapid advances and novel approaches optimizing the use of imaging modalities in cancer care, research and development. This article focuses on the concept of targeted therapy in cancer and the challenges that exist for molecular imaging in cancer care. Springer Berlin Heidelberg 2017-04-10 2017 /pmc/articles/PMC5541087/ /pubmed/28396911 http://dx.doi.org/10.1007/s00259-017-3695-3 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Article Lheureux, S. Denoyelle, C. Ohashi, P. S. De Bono, J. S. Mottaghy, F. M. Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician |
title | Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician |
title_full | Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician |
title_fullStr | Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician |
title_full_unstemmed | Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician |
title_short | Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician |
title_sort | molecularly targeted therapies in cancer: a guide for the nuclear medicine physician |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541087/ https://www.ncbi.nlm.nih.gov/pubmed/28396911 http://dx.doi.org/10.1007/s00259-017-3695-3 |
work_keys_str_mv | AT lheureuxs molecularlytargetedtherapiesincanceraguideforthenuclearmedicinephysician AT denoyellec molecularlytargetedtherapiesincanceraguideforthenuclearmedicinephysician AT ohaships molecularlytargetedtherapiesincanceraguideforthenuclearmedicinephysician AT debonojs molecularlytargetedtherapiesincanceraguideforthenuclearmedicinephysician AT mottaghyfm molecularlytargetedtherapiesincanceraguideforthenuclearmedicinephysician |